The Press File of the International congress of plastic surgery : IMCAS 2012 (January 26-29 th )

1. IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
PRESS
KIT
THURSDAY,
JANUARY
26th
2012

2.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
2
IMCAS
is
one
of
the
most
important
European
Courses
dedicated
to
Plastic
Surgery
and
Cosmetic
Dermatology.
By
welcoming
more
than
3
500
delegates
each
year
during
its
annual
conference,
it
represents
a
true
"medical
population
sampling".
Its
main
objective
is
to
promote
the
highest
possible
standards
in
clinical
practice,
education
and
research
within
the
plastic
surgery
/
dermatology
interface,
as
well
as
in
related
disciplines
(facial
plastic
surgery,
oculoplastic
surgery,
aesthetic
medicine,
research,
etc…).
It's
now
an
institutional
teaching
congress,
working
with
advices
from
several
learned
societies
such
as
the
SOFCEP
(Société
Française
des
Chirurgiens
Esthéticiens
Plasticiens),
the
ESLD
(European
Society
for
Laser
Dermatology)
and
the
ASDS
(American
Society
for
Dermatologic
Surgery).
Benjamin
ASCHER,
French
Board
certified
Plastic
Surgeon
and
IMCAS
Course
Director
The
Course
Coordinators:
David
J
GOLDBERG,
Dermatologist
(United
States)
Bernard
MOLE,
Plastic
Surgeon
(France)
Bernard
ROSSI,
Dermatologist,
(France)
The
Scientific
Secretaries:
Olivier
GERBAULT,
Plastic
Surgeon
(France)
Anne
LE
PILLOUER
PROST,
Dermatologist
(France)
Serge
MORDON,
PhD
–
Research
(France)
Minutes
of
the
International
press
conference
held
on,
January
26th
–
PALAIS
DES
CONGRES
–
Paris

3.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
3
SUMMARY
Facial
and
neck
rejuvenation
–
New
trends
Body
shaping
in
2012
IMCAS
2012:
The
cosmeto
vigilance
watcher
IMCAS
Industry
Tribune:
the
largest
observatory
of
the
aesthetic
market
The
aesthetic
market:
structure,
features
and
trends:
World,
Europe
and
France
A
focus
on
the
Asian
Market:
trends
and
figures
Laurent
BRONES,
Business
Development
Manager,
SYMATESE-­‐
France
Current
and
future
trends
in
lasers
and
energy
based
devices
in
dermatology
Moshe
LAPIDOTH,
Dermatologist
-­‐
Israel
Face
lifting:
fillers
or
surgery?
Neck
Lift:
focus
on
non-­‐invasive
methods
New
trends
in
Botulinum
Toxins
Hyaluronic
Acid:
lift,
volumize,
block
:
Specific
characteristics
comparison
Benjamin
ASCHER,
Plastic
surgeon
–
France
PIP
crisis
:
the
IMCAS
and
the
French
Plastic
Surgery
position
Benjamin
ASCHER,
Plastic
surgeon
–
France-­‐
Scientific
Director
of
IMCAS
congress
Olivier
GERBAULT,
Plastic
surgeon-­‐
France
Bernard
Môle,
Plastic
surgeon-­‐
France
Bruno
Alfandari,
Plastic
surgeon-­‐France
President
of
National
Union
of
Plastic,
Reconstructive
and
Aesthetic
Acellular
dermal
matrix
(ADM):
a
revolution
in
aesthetic
surgery
Olivier
GERBAULT,
Plastic
surgeon
–
France
Getting
nice
buttocks:
how
to
give
them
volume,
to
treat
sagging
and
to
rejuvenate?
Surgical
reshaping:
volume
and
downsides
Raul
GONZALEZ,
Plastic
surgeon
–
Brazil
Cellulite
and
body
shaping:
what’s
hot?
David
J.
GOLDBERG,
Dermatologist-­‐USA
Lipofilling,
what’s
new?
Bernard
MOLE,
Plastic
surgeon-­‐
France
Fat
graft
and
stem
cells:
fundamentals
&
practical
applications
Ali
MOJALLAL,
Plastic
surgeon-­‐
France
IMCAS
as
a
talent
scout:
IMCAS
Business
Incubator
and
IMCAS
AWARDS
Serge
MORDON,
PhD
–
Research,
France
FOR
MORE
INFO,
CLICK
ON:
LA
NUIT
DES
IMCAS
AWARDS
IMCAS
INCUBATORS
IMCAS
WEB
TV
Follow
IMCAS
on
Twitter
Find
IMCAS
on
Facebook
Join
IMCAS
on
Linked
In

4.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
4
IMCAS
INDUSTRY
TRIBUNE
The
largest
observatory
of
the
aesthetic
market
Benjamin
ASCHER,
Plastic
Surgeon,
IMCAS
Course
Director,
FRANCE
Laurent
BRONES,
Business
Development
Manager,
SYMATESE,
FRANCE
Thierry
CHIGNON,
Investment
Director,
MATIGNON
INVESTISSEMENT
&
GESTION,
France
Analysis,
prospects
and
trends
of
the
medical
and
surgical
aesthetic
market,
2010-­‐2016
-­‐
Under
embargo
till
January
26th
included
-­‐
IMCAS
Industry
Tribune
2012,
January
27th
2012
The
Tribune
IMCAS
2012
combines
the
data
available
on
the
medical
&
surgical
aesthetic
market,
supplied
by
the
Market
Studies
Societies
(MRG
&
MII
NEWS),
the
financial
analysts
and
the
industrial
representatives
attending
the
2012
Tribune,
including
Allergan,
Galderma,
Skinceuticals,
Syneron,
as
well
as
the
data
from
the
ISAPS
(International
Society
of
Aesthetic
and
Plastic
Surgery)
Study
on
the
different
procedures
practiced
over
2010.
The
IMCAS
Tribune
thus
realised
an
exhaustive
and
unseen
analysis
on
the
different
territories
(Europe,
USA,
Pacific
Asia,
Latin
America)
between
2010
and
2016,
in
US$,
covering
the
most
important
segments
of
the
market:
botulinum
toxins,
fillers,
active
cosmetics,
lasers
and
energy
devices,
breast
implants.
The
variations
here
observed
between
the
different
information
sources
available
bring
us
to
make
an
evaluation
of
the
different
market
segments
on
two
hypothesis:
one
high,
one
low.
A
bipolar
market:
a
2-­‐gears
growth
Market
facts
and
key
figures
By
Thierry
Chignon
&
Laurent
Brones,
co-­‐coordinators
of
IMCAS
Industry
Tribune
The
world
market
1
is
evaluated
between
3,2
and
3,8
Billions
Euros
for
2011,
i.e.
+
10,1%
compared
to
2010,
with
an
expected
growth
of
+11,2%
in
2012,
being
thus
a
demonstration
of
the
sector's
dynamic
state.
The
European
financial
debt
and
crisis
should
impact
the
European
Market
in
2012,
with
a
growth
estimated
up
to
+5%
between
2012
and
2011.
According
to
our
high
and
low
estimations,
the
European
market
should
be
in
the
range
of
770
–
940
Billions
euros
to
grow
in
2012
to
808
–
985
Billions
Euros.
Beyond
2012
and
depending
of
the
European
Financial
crisis
evolution,
the
Tribune
estimates
the
average
annual
European
growth
between
2012
and
2016
to
be
up
to
+
7%
(10
to
12%
on
the
other
territories.)
Asia
will
know
the
stronger
growth
up
until
2016,
and
will
reach
the
European
market
standards
to
1,1
–
1,3
Billions
Euros
with
an
average
annual
growth
of
15,7%,
against
7%
only
for
Europe.
1
Including
the
sales
activities
from
practitioners,
users
and
distributors

5.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
5
The
United
States
and
Latin
America
will
know
a
growth
of
about
11%.
The
North
America
market
will
still
represent
45%
of
the
global
market.
The
annual
growth
of
the
market
between
2012
and
2016
should
be
of
11,2%,
reaching
5,4
to
6,4
Billions
€.
Regarding
the
different
market
segments,
the
injectable
products
(toxins
and
fillers)
are
still
the
first
market
segment
in
value,
and
will
keep
on
growing
for
an
average
of
+10%
per
year
through
2016,
confirming
their
development
potential
for
many
years.
The
energy-­‐based
devices
(laser,
radiofrequence,
ultrasounds)
will
catch
up
with
the
decrease
in
business
due
to
2008-­‐
2009
financial
crisis,
with
a
average
annual
growth
of
13.2
%
through
2016.
The
cosmeceutics
(active
cosmetics),
new
market
segment
analysis
within
the
Tribune
2012,
will
follow
the
same
trends
than
the
injectable
products.
The
breast
implants
will
know
a
reduced
progression,
estimated
to
5,7%
through
2016,
fitting
the
progressions
observed
those
last
years.
Possibly
subjected
to
an
impact
of
the
PIP
affair,
the
market
could
evolve
in
a
less
favourable
way,
especially
in
Europe.
The
market
segments
are,
sorted
out
by
decreasing
order
of
importance,
are
the
following
ones:
(area
sorted
out
by
decreasing
order)
1. Injectable
products
(Toxins
and
fillers)
a. From
1,22-­‐1,47
Billions
Euros
in
2011,
projected
to
2,04-­‐2,46
Billions
Euros
to
2016
b. Average
annual
growth
2011-­‐2016:
+11,1%
c. Main
areas:
USA,
EU,
Asia,
South
America.
2. Energy
based
devices
a. From
837-­‐981
Billions
Euros
in
2011,
projected
to
1,63-­‐1,91
Billions
Euros
for
2016
b. Average
annual
growth
2011-­‐2016:
+13,2%
c. Main
areas:
USA,
EU
and
Asia
2
,
South
America.
3. Breast
prosthetic
implants:
a. From
637-­‐774
Billions
Euros
in
2011,
projected
to
855-­‐1
039
Billions
Euros
for
2016
b. Average
annual
growth
2011-­‐2016:
+5,7%
c. Main
areas:
USA,
Latin
America,
EU,
Asia.
4. Cosmeceutics
(active
cosmetic)
a. From
515-­‐567
Billions
Euros
in
2011,
projected
to
887-­‐973
Billions
Euros
for
2016,
b. Average
annual
growth
2011-­‐2016:
+11,1%
c. Main
areas:
USA,
Asia,
Latin
America,
EU.
2
The
equipment
market
in
Asia
should
overtake
the
European
market
in
2016

6.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
6
More
than
trends,
social
phenomenon
already:
By
Dr
Benjamin
Ascher,
IMCAS
Congresses
Course
Director
NEW
DEVELOPMENT
AXIS
Aesthetic
surgery:
a
responsible
specialty
On
the
medical
aspect:
techniques
and
products
are
more
and
more
efficient,
especially
when
it
comes
to
the
face,
which
does
not
exclude
an
increased
vigilance
to
optimise
even
more
the
ratio
between
profits
and
risks.
The
wrinkles
fillers,
volumetry
products
and
botulinum
toxins
are
a
good
example:
the
reinforcements
of
controls
regarding
the
entrance
market
authorization
(AMM
for
Toxins,
CE
for
other
medical
devices)
are
already
efficient
for
most
of
them,
but
the
necessity
of
increasing
clinical
studies
preliminary
to
the
products
introduction
to
the
market,
as
well
as
the
selection
of
doctors
empowered
to
practice
those
techniques
are
sine
qua
non
conditions
in
order
to
limit
risks
and
misuses.
In
2012,
a
two-­‐gears
growth,
characterized
by:
-­‐
A
growth
of
about
5%
in
Europe,
compared
to
2011
-­‐
And
a
growth
of
about
15%
in
Asia.
-­‐
Cosmeceutics
(active
cosmetic)
follow
that
growth
trend,
and
the
other
classical
techniques
(peelings,
lasers,
radiofrequences...)
are
even
catching
up
with
the
decrease
of
business
previously
observed
within
their
segment.
Regarding
the
body,
the
controls
and
studies
of
remodelling
devices
and
medical
slimming
products
have
to
get
through
the
same
process
as
the
face:
the
suspension
of
the
decree
forbidding
any
fat
lysing
method
is
only
a
temporary
solution,
which
will
have
to
lead
to
good
processes,
with
a
better
documentation,
especially
when
it
comes
to
phosphatidyl
(a
soy
derivative)
injections,
non
authorized
in
France.
It
is
to
note
than
a
close
molecule,
the
desoxycholine,
is
subjected
to
a
large
clinical
study,
serious
and
multi-­‐centric
in
Europe
and
in
the
U.S.,
to
treat
small
double
chins.
On
the
surgical
aspect,
the
slowdown
expected
in
Europe
is
limited
Breast
implants
are
subjected
to
a
progression
of
about
6%,
fitting
the
last
data
observed
those
past
years.
The
general
progression
for
surgery
presents
also
2
gears:
+7%
in
Europe
against
+11,1%
in
the
US
but
most
of
all
+15,7%
in
Asia.
The
2
most
popular
interventions
are
still,
in
the
world
as
well
as
for
each
geographical
area,
the
liposuction
and
the
breast
augmentation
with
prosthetic
implants.
But
the
lipofilling
knows
a
more
and
more
important
development.
NEW
TRENDS
IN
2011
1
–
The
trend
for
natural:
in
France,
in
Europe,
in
USA
and
more
and
more
worldwide,
the
tend
imposing
itself
nowadays
is
to
restore
and
maintain
at
patients
a
beauty
un-­‐stereotyped,
without
the
need
to
"look
young
at
any
cost".
2
–
A
more
localised
surgical
lifting:
whether
it's
done
for
the
face,
the
arms
or
the
internal
face
of
the
tights,
the
lifting
is
now
less
global,
less
invasive,
with
shorter
scars.
The
objective
is
to
never
nip
or
tuck
against
nature
and
getting
more
discreet
scars.
3
–
Non-­‐invasive
therapies:
in
2012,
important
innovations
are
expected,
especially
with
new
toxins,
which
will
appear
on
the
scientific
change
within
the
coming
months.
4
–
More
and
more
combined
techniques:
non-­‐invasive
techniques
are
combined
to
one
another,
like
toxin
for
the
upper
face
and
hyaluronic
acid
for
the
lower
face.
Moreover,
those
techniques
are
not
in
opposition
with
surgery
but
prepare
or
maintain
the
surgical
gesture.
The
treatments
are
thus
more
and
more
combined
within
a
single
and
precise
therapeutic
program.

7.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
7
Surgical
interventions
and
non-­‐invasive
procedures:
the
top
5
According
to
ISAPS
data,
the
USA,
Latin
America,
Europe
and
Asia
represents
respectively
24,6%,
19,6%,
21,4%
and
31,7%
of
the
surgical
interventions
practiced
worldwide,
thus
revealing
the
success
of
plastic
surgery
in
India
and
China.
WORLDWIDE,
the
surgical
interventions
the
most
practiced
are,
here
sorted
out
by
decreasing
order
(countries
sorted
by
decreasing
order):
1. Liposuction:
Brazil,
USA,
China,
India,
Japan
2. Breast
augmentation
USA,
Brazil,
Mexico,
Italy
China
3. Blepharoplasty
(eyelids):
Brazil,
USA,
China,
India,
Japan,
Italy
4. Rhinoplasty:
Brazil,
USA,
China,
Japan,
India
5. Abdominoplasty
(tummy
tuck):
USA,
Brazil,
Mexico,
India,
China
WORLDWIDE,
the
non-­‐invasive
procedures
the
most
practiced
are,
here
sorted
out
by
decreasing
order
(countries
sorted
by
decreasing
order):
1. Botulinum
toxin:
USA,
Brazil,
China,
Japan,
Mexico
2. Hyaluronic
acid:
USA,
China,
Japan,
Italy,
Brazil,
3. Lipofilling:
Brazil,
USA,
China,
Japan,
India
4. Laser
hair
removal:
USA,
Brazil,
China,
Japan,
India
5. IPL
Laser
treatment:
USA,
Brazil,
Japan,
China,
India
In
EUROPE,
the
surgical
interventions
the
most
practiced
are,
here
sorted
out
by
decreasing
order
(countries
sorted
by
decreasing
order):
1. Breast
augmentation:
Italy,
France,
Germany,
Spain,
Russia
2. Liposcution:
Italy,
Turkey,
France,
Germany,
Spain
3. Blepharoplasty:
Italy,
France,
Germany,
Turkey,
Spain
4. Breast
reduction:
Italy,
France,
Germany,
Turkey,
Spain
5. Breast
lift:
Italy,
France,
Germany,
Spain,
Russia
In
EUROPE,
the
non-­‐invasive
procedures
the
most
practiced
are,
here
sorted
out
by
decreasing
order
(countries
sorted
by
decreasing
order):
1. Hyaluronic
acid:
Italy,
France,
Germany,
Spain,
Turkey
2. Botulinum
toxin:
Italy,
France,
Turkey,
Germany,
Spain
3. Lipofilling
:
Italy,
France,
Turkey,
Germany,
Spain
4. Laser
hair
removal:
Turkey,
Italy,
France,
Germany,
Spain
5. IPL
Laser
treatment:
Italy,
Turkey,
France,
Germany,
Spain
In
ASIA,
the
surgical
interventions
the
most
practiced
are,
here
sorted
out
by
decreasing
order
(countries
sorted
by
decreasing
order):
1. Liposuction:
China,
India,
Japan,
South
Korea,
Taiwan
2. Rhinoplasty:
China,
Japan,
India,
South
Korea,
Taiwan
3. Blepharoplasty:
China,
Japan,
India,
South
Korea,
Taiwan
4. Breast
augmentation:
China,
India,
Japan,
South
Korea,
Taiwan
5. Abdominoplasty:
India,
China,
Japan,
South
Korea,
Taiwan

8.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
8
In
ASIA,
the
non-­‐invasive
procedures
the
most
practiced
are,
here
sorted
out
by
decreasing
order
(countries
sorted
by
decreasing
order):
1. Botulinum
toxin:
China,
Japan,
India,
South
Korea,
Taiwan
2. Hyaluronic
acid:
China,
Japan,
India,
South
Korea,
Taiwan
3. Lipofilling:
China,
Japan,
India,
South
Korea,
Taiwan
4. Laser
hair
removal:
China,
Japan,
India,
South
Korea,
Taiwan
5. IPL
Laser
treatment:China,
Japan,
India,
South
Korea,
Taiwan
In
FRANCE,
the
breast
surgery
is
still
a
major
concern
for
women
since
the
most
practiced
interventions
are:
1. Breast
augmentation
50
519
2. Liposuction
44
181
3. Blepharoplasty
(eyelids)
44
133
4. Breast
reduction
17
535
5. Breast
ptosis
16
878
The
non-­‐invasive
procedures
have
been
generalized
in
France
and
the
hyaluronic
acid
and
botulinum
toxin
injections
are
now
the
leads:
1. Hyaluronic
Acid
Injections
84
445
2. Botulinum
Toxin
Injections
81
815
3. Lipofilling
21
595
4. IPL,
Laser
treatments
12
856
5. Laser
hair
removal
11
303
IMCAS:
the
Alert
Congress
IMCAS
did
not
wait
for
the
PIP
crisis
to
make
vigilance
one
of
its
main
concern,
and
specially
this
year
by
organizing
the
following
sessions:
• Sessions
comparisons
of
hyaluronic
acids,
toxins
and
lasers,
independent
from
the
Industry
• Session
fillers
complications,
featuring
the
results
of
the
first
worldwide
survey
on
the
topic
• Session
operative
safety
in
dermatology
and
plastic
surgery
• Session
European
vigilance
in
dermatologic
and
surgical
aesthetic,
• To
which
was
just
added
the
session
dedicated
to
the
PIP
crisis
About
IMCAS
Leader
European
congress
dedicated
to
plastic
surgeons,
dermatologists
and
different
experts
of
the
medical
and
surgical
aesthetic
practice,
IMCAS
(January
26
to
29,
2012)
has
became
in
14
years
one
of
the
most
important
worldwide
meeting
of
the
profession.
This
event
welcomes
each
year
more
than
4
000
attendees
from
60
different
countries.
That
exchange
between
the
most
eminent
international
specialists
made
IMCAS
the
reference
in
excellence
when
it
comes
to
education
and
information.
Its
main
objective
is
to
promote
the
highest
possible
standards
in
clinical
practice,
education
and
research
within
the
plastic
surgery
/
dermatology
interface,
as
well
as
in
related
disciplines
(maxilla-­‐facial
surgery,
aesthetic
medicine,
anti
aging...)
IMCAS
exports
itself
worldwide
with
3
other
meetings:
IMCAS
(New
Delhi)
IMCAS
ASIA
(alternatively
in
Singapore,
Hong
Kong,
Bangkoe),
IMCAS
CHINA
(Shanghai).

9.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
9
Face
lifting:
fillers
or
surgery?
Neck
Lift:
focus
on
non-­‐invasive
methods
New
trends
in
Botulinum
Toxins
Hyaluronic
Acid:
lift,
volumize,
block:
Specific
characteristics
comparison
Benjamin
ASCHER,
Plastic
surgeon
–
France
Hyaluronic
acid:
to
lift,
volumize,
block
What
can
fillers
do?
Fillers,
especially
hyaluronic
acids,
are:
• either
injectable
products,
of
moderate
thickness,
to
fill
wrinkles
• either
thicker
injectable
products
to
give
some
volume
(volumize)
They
can:
Ø Moderately
stop
or
slow
down
the
skin
and
muscles
slippage:
there
is
indeed
3
face
areas,
located
on
the
front,
where
tissues
slip
down,
tip
and
form
lines:
naso-­‐labial
fold
(between
the
nose
and
the
upper
lip)
bitterness
line
(between
the
lip
and
the
chin),
mandibular
notch
(between
chin
and
oval).
A
good-­‐positioned
volumator
on
the
front
of
those
lines
can
fight
the
slip
down
from
some
of
it.
Ø Volumize
the
hollow
areas:
volumators
will
there
be
active
for
face
areas
in
the
middle
of
the
face:
the
tears
valley,
the
temples,
the
eye
rings,
the
orbital
hollows
but
also
the
cheekbones
and
the
nose.
The
idea
is
to
restore
the
lost
or
missing
volumes
and
contours.
2
misuses
are
to
proscribe
for
they
lead
to
caricature:
the
"balloon-­‐shaped"
faces,
the
triangular
faces
becoming
"square-­‐shaped".
If
fat
is
still
one
of
the
best
transplant
material,
volumators
have
many
advantages,
such
as:
no
need
to
go
to
the
O.R.,
no
harvesting
area,
painless
injection
with
local
anaesthesia
or
cream,
fewer
oedemas
and
bruises,
especially
with
the
almost
systematic
use
of
blunt
tip
micro-­‐cannulas.
Ø Moderately
lift
the
ptosis:
fillers
can
moderately
get
some
back
face
areas
upper
when
they
had
slip
down:
the
external
eyebrow,
the
temple,
the
cheek,
and
the
upcoming
jaw
sagging
and
the
tip
of
the
nose.
But
when
a
real
slid
down
of
the
tissues
has
happened:
sagging
regard,
real
jaw
sagging,
the
injection
cannot
do
anything
by
itself.
It
can
dissimulate
the
sagging
without
really
treating
it.
Only
a
lifting
(or
if
the
patient
is
not
ready,
pink
threads)
can
make
the
tissues
get
upper
and
thus
give
the
wanted
refreshed
face.
If
we
inject
too
much,
we
obtain
a
"balloon
effect".
Lifting:
injectable
products
or
surgery?
Ø Evolution
of
the
surgical
lifting:
whether
it's
for
the
upper
or
lower
face,
the
arms
or
the
tights,
the
lifting
is
now
less
global,
less
invasive.
We
don't
peel
the
tissue
as
much
as
before,
the
gesture
is
more
focused,
more
durable,
and
more
discreet
with
shorter
scars.
A
successful
lifting
is
a
natural
one,
which
doesn't
make
the
face
looks
lifted
or
tucked.
Ø Volumators:
If
fat
is
still
one
of
the
best
volumator,
hyaluronic
acids
have
several
advantages:
the
blunt
tip
micro
cannulas
improve
the
patient's
comfort.
But
the
lipofilling
is
more
and
more
developed
with
a
new
trend:
the
superficial
fat
injection,
which
improves
skin
texture.
-­‐
Careful
with
excesses,
that
make
«balloon-­‐shaped»
faces.

10.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
10
Ø For
a
global
treatment:
When
surgery
is
not
necessary
or
not
wanted:
botulinum
toxin,
fillers,
radiofrequency
and
soft
lasers
give
a
very
efficient
global
effect.
When
surgery
is
necessary:
sagging
regard
or
real
jaw
sagging:
lifting
is
the
course
of
action
Associated
with
lifting,
injections,
surface
lasers
are
going
to
decrease
the
invasive
aspect
of
that
surgery,
for
people
ask
for
an
active
but
non-­‐incapacitating
treatment.
The
true
revolution
is
actually
in
the
step-­‐by-­‐step
process.
We
first
choose
a
really
efficient
treatment
but
as
less
invasive
as
possible.
If
a
surgery
is
decided,
it
fits
itself
in
a
therapeutic
plan.
• Prepare,
with
botulinum
toxin
and
fillers
• Lift,
at
the
right
time,
by
associating
fillers
or
fat
• Maintain,
by
fillers
and
toxin,
to
avoid
a
possible
second
lifting.
Far
for
being
in
opposition,
those
treatments
optimize
each
other,
as
long
as
the
right
plan
and
the
right
timing
are
chosen.
Fillers
and
toxin
can
allow
delaying
some
surgeries
(such
as
upper
face).
Did
they
replace
it?
No,
but
they
optimize
the
immediate
results
as
well
as
the
long-­‐term
results.
And
in
most
of
cases,
they
can
produce
by
themselves
a
slow
down,
even
sometimes
a
true
prevention
of
aging.
What
can
we
expect
from
cosmetic
botulinum
toxin
for
tomorrow?
There
are
3
toxins
available
in
Europe,
efficient
and
safe,
elsewhere;
Chinese
and
Korean
toxins,
as
well
as
American
toxin
are
used.
The
innovation:
-­‐ A
toxin
used
as
a
cream:
the
Revance
(from
California)
will
be
operative
in
2013.
This
is
a
real
"medicine
cream"
which
has
nothing
to
do
with
"magical"
cosmeceutics
cream,
actually
inactive,
with
Ox-­‐names
destined
to
make
people
dream.
-­‐ The
hyaluronic
acid,
immediately
mixed
with
small
quantity
of
toxin
can
be
superficially
injected
in
areas
which
were
so
far
not
indicated
for
toxin
treatment,
such
as
cheekbones
and
cheeks.
-­‐ The
cryoneuro-­‐modulator
realises
forehead
nerve
refrigeration
which
lead
to
a
durable
"botox
like"
effect:
it's
expected
to
be
launched
in
September
2012.
-­‐ Toxins
seem
to
maintain
an
important
growth,
around
+10%
in
Europe,
through
2016
Focus
–
neck
and
jaw
sagging,
the
soft
treatments
Radiofrequency,
hyaluronic
acids
injections
in
horizontal
wrinkles,
vertical
muscular
chord
treatments
can
lead
to
partial
but
durable
results
if
regularly
repeated,
but:
-­‐ If
there's
a
real
fat
mass:
only
liposuction
can
treat
it,
but
desoxycholate
injections
could
be
a
good
treatment
for
small
mass
within
a
year
-­‐
If
there's
a
real
slackness
of
skin
and
muscles,
neck
lifting
is
the
right
course
of
action.
Pink
threads
don't
treat
the
neck,
only
the
lower
face
and
for
2
years
top.
-­‐
Neck
lifting
systematically
includes
the
oval:
the
retightening
of
neck
by
lifting
is
always
associated
to
a
harmonious
pull
up
of
the
oval.
It's
the
same
unit
that
has
to
be
treated
to
obtain
a
natural
result.
When
oval
gets
blurry,
lipofilling
reinforce
in
a
natural
way
the
contours
thus
the
result.

11.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
11
PIP
crisis:
the
IMCAS
and
the
French
Plastic
Surgery
position
IMCAS
Congresses
and
PIP
Crisis
Benjamin
Ascher,
MD,
IMCAS
Scientific
Director
Bernard
Mole,
MD
IMCAS
Surgical
segment,
Course
Coordinator
Olivier
Gerbault,
MD,
IMCAS
Surgical
segment,
Scientific
Secretary
MCAS
is
supporting
the
French
Plastic
Surgeons
Union,
the
two
French
Plastic
Surgery
Societies
(SOFCPRE,
SOFCEP)
as
well
as
the
European
and
International
Aesthetic
Surgery
Societies
(EASAPS
and
ISAPS)
in
taking
care
of
PIP
patients.
IMCAS
Annual
Meeting
2012
has
invited
major
world
famous
experts
(surgeons,
engineers)
in
breast
implants
and
breast
surgery
to
share
insights
on
how
to
manage
PIP
implants
and
proposals
to
avoid
similar
issues.
IMCAS
-­‐
the
Alert
Congress:
IMCAS
has
gathered
surgeons,
other
experts
in
aesthetical
medicine
and
industrials
for
14
years
to
exchange
on
each
other's
expectations.
IMCAS
is
concerned
about
safety
and
has
set
up
an
alert
task
force
on
medical
devices
and
fillers
for
several
years.
This
year
IMCAS
is
going
to
publish
the
results
of
a
worldwide
survey
on
fillers
complications
and
has
put
within
its
program
some
sessions
independent
from
the
industry,
dedicated
to
patient
safety,
cosmeto
and
materio-­‐
vigilance
and
products
(lasers,
hyaluronic
acids,
toxins...)
comparison
Mammary
Implants
and
cancer:
Regarding
breast
implants,
no
link
between
any
types
of
breast
implants
and
breast
cancer
has
been
established
in
more
than
30
years
of
international
studies
and
surveys
realized.
Breast
cancer
is
the
most
frequent
cancer
in
women
(around
10%),
and
it
is
expected
that
some
of
the
women
who
had
a
breast
augmentation
(regardless
of
the
implant’s
brand)
experience
a
breast
cancer
at
some
point
in
their
life,
like
could
experience
any
other
woman
with
or
without
implants.
When
it
comes
to
the
PIP
implants,
some
of
them
are
filled
with
a
non-­‐medical
silicone
gel
that
may
irritate
the
breast
and
surrounding
tissues
much
more
than
a
medical
gel,
especially
in
case
of
leakage.
That
gel
may
extrude
and
disseminate
more
easily
than
medical
gel.
This
is
the
reason
why
a
systematic
removal
of
the
defective
implants
has
been
asked
by
the
French
Plastic
and
Aesthetic
Surgery
societies
and
the
French
Plastic
Surgeons
Union.
For
the
majority
of
the
patients
who
have
breast
implants:
these
devices
remain
a
secure
device,
and
breast
augmentation
is
one
of
the
2
TOP
worldwide
requested
procedures
in
aesthetic
surgery,
with
the
higher
degree
of
patients'
satisfaction.
However,
controls
should
be
reinforced
to
guarantee
that
the
highest
quality
standards
requested
for
breast
implants
manufacturing
are
respected
as
well
as
make
sure
than
feedback
about
complications
is
provided
to
both
scientific
societies'
and
health
ministry's
vigilance
task
forces.

12.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
12
The
International
PIP
Health
Crisis
Bruno
Alfandari
–
Plastic
surgeon-­‐France,
President
of
National
Union
of
Plastic,
Reconstructive
and
Aesthetic
The
PIP
case
is
a
major
health
crisis.
It
affects
30,000
of
our
patients
in
FRANCE
and
nearly
500,000
patients
worldwide.
Our
union,
The
Representative
Organization
of
French
Plastic
Surgeons,
has
immediately
filed
a
complaint
to
shed
light
on
this
case,
and
has
requested
that
those
responsible
for
this
situation
be
identified.
In
the
meantime,
we
have
asked
our
surgeons
to
inform
all
their
patients
about
this
issue
and
to
begin
the
removal
of
all
poor
quality
implants
without
delay.
To
date;
more
than
2,000
patients
have
already
been
treated.
The
French
government,
along
with
other
countries
including
Germany
and
England,
has
endorsed
our
recommendations
of
preventive
surgery.
And
today
we
have
decided
to
take
our
commitment
a
step
further.
We
believe
it
is
necessary
to
remove
ALL
PIP
silicone
gel
implants
without
exception,
until
the
end
of
the
moratorium.
Our
profession
is
committed
to
do
so
as
quickly
as
possible
and
under
the
best
conditions
available.
Our
patients
must
know
that
they
can
count
on
us
through
this
ordeal.
We
owe
our
patients
the
utmost
security
and
we
will,
with
the
help
of
the
authorities,
do
everything
within
our
power
to
prevent
a
health
issue
of
this
scale
from
ever
arising
in
the
future.

13.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
13
Acellular
dermal
matrix
(ADM):
a
revolution
in
aesthetic
surgery
Dr.
O
GERBAULT
–
Plastic
surgeon,
France
Acellular
dermal
matrixes
have
profoundly
changed
aesthetic
and
reconstructive
breast
surgery,
but
also
rhinoplasties
and
they
could
play
a
significant
role
in
facial
rejuvenation.
ADM
are
flexible
sheets
of
collagen
reproducing
the
three-­‐dimensional
structure
of
the
dermis,
but
devoid
of
all
the
dermal
cells.
This
natural
dermis
can
be
of
human,
bovine
or
porcine
origin.
Their
antigenicity
has
been
eradicated
by
a
chemical
process,
avoiding
any
rejection.
The
MDA
gradually
integrates
the
body,
as
if
it
was
the
own
dermis
that
was
grafted
wherever
desired.
ADM
have
been
used
in
different
types
of
surgery
for
more
than
10
years.
Their
application
in
plastic
and
aesthetic
surgery
is
recent,
and
growing.
The
current
major
disadvantage
of
the
MDA
is
their
cost,
but
it
should
significantly
decrease
because
of
the
increasing
number
of
laboratories
marketing
this
product.
This
dermal
matrix
has
a
triple
interest:
-­‐ Reinforcement
of
a
weak
anatomic
area:
this
property
is
used
in
breast
implant
reconstruction,
to
strengthen
the
operated
breast
skin
which
was
traumatized
by
the
surgery,
the
radiations…
This
reinforcement
allows
breast
implant
reconstruction
to
be
much
more
reliable
and
simple.
ADM
are
also
useful
in
case
of
unfavourable
result
after
breast
augmentation,
when
implants
have
been
poorly
positioned
at
the
first
operation,
or
when
the
skin
is
very
thin
to
avoid
(or
treat)
folds
or
edges
visibility.
-­‐ Camouflage
of
visible
irregularities
after
surgery:
this
property
is
now
used
in
Rhinoplasty,
including
for
people
with
a
thin
skin,
but
also
for
re-­‐operation
of
the
nose.
This
ADM
sheet
is
positioned
between
the
reshaped
bone
and
cartilage
and
the
skin,
to
avoid
imperfections
visibility
after
a
rhinoplasty
(preventive
camouflage),
but
also
to
treat
them
during
a
revision
procedure.
-­‐ Volumetric
augmentation:
this
property
is
used
in
Rhinoplasty
(over
resected
noses,
or
too
flat
noses,
which
is
often
the
case
for
ethnic
rhinoplasties:
in
the
African,
Caribbean,
Asian,etc.),
but
also
in
facial
rejuvenation
to
compensate
for
the
loss
of
volumes
with
age,
but
also
to
increase
the
volumes
of
too
hollow
faces,
or
flat
faces.
Finally,
ADM
has
already
changed
the
face
of
some
areas
of
aesthetic
and
reconstructive
surgery
and
will
likely
be
the
new
natural
tomorrow's
aesthetic
surgery
implant.

14.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
14
Buttocks
Implants
How
to
obtain
a
perky
and
nice
“derriere”
Raul
GONZALEZ
-­‐
Plastic
surgeon,
Brazil
On
the
past
Thirty
years
ago,
on
the
70
th
’s,
there
wasn’t
any
specific
aesthetic
procedure
to
improve
the
buttocks
appearance,
except
some
techniques
for
gluteal
lifting
with
scars.
There
was
no
fat
grafting
and
liposuction
and
90%
of
the
aesthetic
surgeries
were
done
in
the
anterior
part
of
the
body.
So,
the
aesthetic
surgery
of
the
body
was
very
limited.
The
first
buttocks
implants
In
1980
the
Mexican
surgeon
Gonzalez-­‐Ulloa,
idealized
a
gluteal
implant
to
be
placed
in
the
gluteal
fat,
this
implant
was
accompanied
by
a
myriad
of
complications,
and
had
a
very
short
story,
which
was
quickly
forgotten.
In
1984
an
Argentine
surgeon,
Jose
Robles,
introduced
a
technique
to
put
the
implant
implant.
The
Brazilian
experience,
the
first
fat
grafting
to
remodel
the
buttocks.
In
1984
I
began
to
use
the
fat
of
liposuction
to
remodel
the
buttocks,
increasing
the
volume
and
filling
the
lateral
depressions.
These
were
the
first
non
incisional
procedures
approaching
the
buttocks
all
over
the
world.
My
experience
was
published
in
1986
and
was
the
first
medical
article
to
show
this
possibility.
Brazil
is
a
tropical
country;
the
beaches
are
crowded
throughout
the
whole
year.
Bikinis
are
part
of
the
Brazilian
clothing.
The
Brazilian
surgeons
were
very
receptive
with
this
new
procedure
and
very
quickly
begun
to
spread
out
“the
Brazilian
buttocks
lift”,
the
name
this
procedure
received
in
USA.
The
gluteal
implants,
the
Brazilian
technique
In
1986
I
started
to
perform
submuscular
buttocks
implants,
the
Argentinian
method.
After
some
experience
I
begun
to
notice
the
failures
of
this
technique
and
I
changed
to
use
the
implants
inside
the
gluteus
maximus
muscle,
that
is,
intramuscularly.
Some
years
after,
I
published
a
medical
article
showing
my
method.
The
Gonzalez
XYZ
technique,
as
is
called.
A
book
to
teach
“Buttocks
reshaping”
In
1989
I
begun
to
publish
several
medical
articles
to
spread
out
my
techniques
about
buttocks
improvement,
including
fat
grafting,
lipofilling,
implants,
lifting,
treatment
of
gluteal
retraction
and
many
others
procedures
I
developed.
The
collection
of
these
contributions
gave
rise
to
a
book
called
“GLUTEOPLASTY
OR
BUTTOCKS
RESHAPING”
translated
into
several
languages
such
as
Korean,
Italian,
Spanish,
Portuguese,
English
and
Chinese,
the
next
edition.
The
book
was
launched
in
2006
and
immediately
the
surgeons
over
the
world
answered.
In
some
countries
as
on
Brazil,
Colombia
and
Venezuela,
the
numbers
of
buttocks
implants
procedures
double
in
less
than
two
years
after
the
book.

15.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
15
The
importance
of
buttocks
on
human
being
Among
thousands
of
mammal
species
and
about
two
hundred
primates,
man
is
the
only
one
to
have
buttocks,
or
at
least
a
nice
perky
volume
projected
at
the
base
of
the
spine.
The
most
plausible
explanation
for
that
is
that
when
our
quadruped
ancestors
learned
to
keep
their
balance
on
two
hind
legs,
they
had
to
develop
the
posterior
muscles
of
the
hips
in
order
to
stand
erect.
The
importance
of
the
buttocks
for
the
female
contour
There
is
a
fundamental
difference
between
the
female
and
the
male
body.
A
woman’s
body
is
characterized
by
curvy,
shapely
lines
and
round
volumes,
while
a
man’s
body
is
characterized
by
straight
lines
and
square
volumes.
Prominent
and
projected
volumes,
like
the
breast
and
buttocks,
are
exclusive
features
of
the
female
body.
The
importance
of
the
buttocks
on
sexuality
In
human
beings,
the
differences
between
male
and
female
are
essential
to
stimulate
inter-­‐sexual
relations.
Opposite
poles
attract
and
the
differences
are
a
woman’s
major
attraction
in
her
relationship
with
a
man.
Somehow,
the
most
evident
sexual
features
in
a
human
female
figure
have
to
do
with
procreation:
the
breasts
for
nursing,
and
the
pelvis
larger
than
a
man’s
for
birth.
Those
are
precisely
the
two
sexual
features
of
a
woman’s
body
that
bear
the
greatest
differences
between
a
woman’s
and
a
man’s
body;
coincidently,
they
are
the
ones
made
of
more
curvy
lines
and
projection.
The
modern
aesthetic
surgery
of
the
buttocks
Implants,
lipofilling,
liftings,
liposuction
and
many
others
aesthetic
interventions
aiming
buttocks
appearance
are
part
of
the
routine
in
most
of
the
surgical
centers
nowadays.
In
some
countries
more
than
others.
And
they
continue
to
gain
popularity
all
over
the
world.
Implants
are
reaching
a
rule
on
this
scenario,
it
is
the
best
way
to
achieve
a
perky
and
nice
buttocks.

16.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
16
Cellulite
and
Body
Shaping.
What
is
Hot?
David
J.
Goldberg,
Dermatologist
-­‐
USA
Non-­‐surgical
body
contouring,
initially
used
on
the
face,
is
now
being
used
off
the
face
and
for
cellulite
improvement.
Various
approaches
have
been
used.
These
include
laser
and
light
based
technology,
radiofrequency
approaches,
and
the
use
of
focused
ultrasound.
This
talk
will
focus
on
2
very
new
different
technologies
for
body
contouring.
One
method
(Bella
Contour)
leads
to
immediate,
albeit
temporary,
improvement
in
body
contouring.
The
second
approach
(Cellulaze)
represents
a
radically
different
approach
to
cellulite
that
may
lead
to
long-­‐term
or
permanent
improvement.
Bella
Contour
uses
a
combination
of
electrodes
placed
on
the
skin,
ultrasound
and
vacuum
massage
to
create
holes
in
fat
cells
(adipocytes).
Treatment
is
painless
and
improved
results
are
seen
immediately
after
treatment.
Generally
5-­‐10
treatments
are
required.
Because
results
are
temporary,
periodic
re-­‐treatments
are
required.
The
technology
has
both
CE
and
FDA
approval.
Cellulaze
is
laser
that
approaches
the
3
different
skin
regions
that
are
thought
to
lead
to
cellulite
formation.
The
fat,
bands
between
the
fat,
and
overlying
thin
skin
are
all
treated.
Long
term
results
have
been
reported.
Currently
this
device
has
CE
clearance,
but
is
pending
FDA
approval.
Non-­‐invasive
body
contouring
and
successful
cellulite
treatment
have
finally
arrived!

17.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
17
Fat
injection
vs.
foreign
body
filling:
assets
and
limits.
(Lipofilling,
fat
transplantation…)
Bernard
Mole
–
Plastic
surgeon,
Paris
In
an
attempt
to
adopt
a
more
ecological
approach,
fat
transplantation
is
undoubtedly
the
best
course
of
action
in
the
repair
of
a
loss
of
cosmetic
tissue:
fat
is
a
living
material,
stemming
from
ones
own
body,
renewable,
and
theoretically
“eternal”.
On
the
one
hand
“lipofilling”
has
its
limits,
due
to
the
possibility
that
the
amounts
required
may
not
even
exist
in
patients
whose
reserves
have
been
exhausted
by
disease
(e.g.:
HIV)
or
high
catabolism.
However
on
the
other
hand
the
issue
of
high
fat
growth
brings
to
dramatic
questions
concerning
its
long-­‐term
safety
in
particularly
prone
areas
such
as
the
breasts.
In
the
French
Plastic
and
Aesthetic
Surgery
Society
there
is
a
very
apparent
clash
between
the
supporters
of
this
method,
who
for
the
past
decade
have
carefully
studied
the
consequences
of
this
act,
and
those
who
are
upseted
by
the
"precautionary
principle
enshrined
in
the
Constitution,"
recommending
a
“wait-­‐and-­‐see”
attitude.
Nevertheless,
a
tentative
step
forward
was
taken
at
the
last
Congress,
adopting
the
recommendation
to
young
women
(25
and
under)
with
no
family
history
of
breast
cancer,
and
willing
to
moderate
increases
in
the
chest
to
whom
“lipofilling”
may
now
be
available.
The
PIP
breast
implant
crisis
will
likely
speed
up
the
process,
as
over
a
period
of
weeks
a
feeling
of
distrust
has
arisen
in
many
patients
concerning
silicone
breast
implants.
This
distrust
has
its
place
among
various
sources,
including
an
extremely
poor
media
onslaught
for
which
you,
the
media,
are
directly
responsible.
The
panic
of
the
female
population
in
recent
weeks
is
indescribable
and
not
based
on
any
objective
data.
These
are
plastic
surgeons
who
must
accept
the
consequences
of
this
extremely
alarmed
atmosphere,
for
which
there
is
no
true
foundation.
Among
the
recipients
of
likely
defective
implants
(30
000
women),
3000
will
inevitably
suffer
from
the
onset
of
breast
cancer,
with
or
without
implants.
Under
such
circumstances
it
should
be
wiser
to
forbid
forever
all
motorcars
responsible
for
a
considerably
higher
annual
death
toll!

18.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
18
Fat
graft
and
stem
cells:
fundamentals
&
practical
applications
Ali
MOJALLAL
–
Plastic
surgeon,
France
Among
patients
and
physicians,
the
ability
to
remove
unwanted
fat
from
an
area
of
the
body
and
re-­‐inject
it
into
a
more
desirable
location
(fat
grafting)
is
one
of
the
most
fascinating
treatments
in
the
field
of
aesthetic
surgery.
The
transplantation
of
adipose
tissue
is
a
meticulous
technique
using
specific
instruments
and
a
strict
methodology.
Its
application
in
the
fields
of
the
face,
breasts
and
extremities
surgery
showed
very
high
satisfactory
results,
consistent
and
reliable.
Recently
it
was
shown
that
not
only
adipose
tissue
could
restore
the
missing
volumes,
but
it
also
had
regenerative
capacity.
Indeed,
since
a
about
a
decade,
we
know
that
adipose
tissue
(fat
tissue)
is
the
largest
source
of
mesenchymal
stem
cells.
These
cells
are
used
for
tissue
engineering
and
regenerative
medicine.
Therefore,
when
we
do
a
fat
transplant
(fat
grafting
or
lipo-­‐filling),
we
put
together
a
quantity
of
stem
cells.
The
advantages
of
using
stem
cells
from
fat
are:
(1)
the
ability
to
continue
to
proliferate
after
transplantation
because
these
cells
are
more
resistant
(2)
the
differentiation
of
these
cells
into
multiple
cell
lines
according
to
the
recipient
area,
(3)
the
release
of
angiogenic
growth
factors
and
transforming
stem
cells
into
endothelial
lineage
increasing
neovascularization
that
is
to
say,
improving
blood
flow
of
the
recipient
tissue.
These
advantages
are
particularly
attractive
for
elderly
patients
because
the
stem
cells
would
improve
the
vascularization
of
tissue
and
therefore
would
improve
the
quality
of
tissues
at
the
site
of
injection.
The
combination
of
volume
restoration
and
regenerative
capacities
of
fat
via
stem
cells
is
a
key
element
in
rejuvenation
cosmetic
surgery
and
in
regenerative
medicine.

19.
PRESS
FILE
–
Paris
-­‐
January
2012
IMCAS
PRESS
OFFICE
-­‐
P.B
Communication
7
Villa
des
Sablons–
92200
Neuilly
sur
Seine
-­‐
Tel
:
+
33
1
47
31
11
06
-­‐
E-­‐mail
:
pbcom@wanadoo.fr
www.imcas.com
19
IMCAS
as
a
talent
scout:
IMCAS
Business
Incubator
and
IMCAS
AWARDS
Serge
MORDON,
PhD
–
Research,
France
The
2012
IMCAS
Incubator
The
purpose
of
the
IMCAS
Incubator,
coordinated
by
Serge
Mordon,
PhD,
research
director
of
INSERM
in
Lille,
France,
is
to
enable
innovative
ideas,
techniques
and
technologies,
developed
by
physicians
–
and
not
yet
submitted
for
further
evaluation
–
to
be
presented
for
the
first
time
to
research
and
development
(R&D)
executives
from
the
world’s
leading
companies
in
the
aesthetic
industry.
A
specific
session
will
teach
attendees
how
to
access
relevant
clinical,
business
and
capital
resources.
Experts
in
technology
transfer
have
been
invited:
Thierry
Bruhat,
International
Research
Consultant,
will
present
the
different
Technology
Transfer
systems
in
the
United
States
and
in
Europe
Natalène
Hoepffner,
Licensing
-­‐
Alliance
Manager,
Galderma
International,
will
explain
the
expectations
of
the
companies
of
such
an
incubator
Gabriel
Colboc,
Lawyer,
will
share
his
experience
in
initiating
and
negotiating
Transfer
Contract.
Furthermore,
the
IMCAS
Incubator
will
include
a
Speed
Dating
Corner,
created
to
optimize
and
support
exchanges
between
attendees
and
the
relevant
management
of
the
attending
industry.
Over
two
hours,
at
intervals
of
15
minutes,
innovative
face
or
body
treatment
techniques
and
technologies
will
be
presented
to
R&D
executives
from
the
aesthetic
industry.
Thanks
to
the
IMCAS
Incubator,
IMCAS
will
hopefully
become
an
important
talent
scout
IMCAS
AWARDS
Dedicated
to
reward
some
of
our
best
practitioner
for
their
clinical
studies/trials,
medical
or
surgical,
of
2011
15
nominees
4
of
them
will
be
granted
with
an
award
of
an
amount
of
2000
euros.